Insulin lispro Sanofi

Medicinal product

(Invented) name

Insulin lispro Sanofi

Active substance (s)

Insulinas lispro

Strength

100 V/ml

Pharmaceutical form

injekcinis tirpalas flakone

Route (s) of administration

leisti į veną, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10AB04, Insulin lispro

Marketing authorisation holder

Sanofi Winthrop Industrie, Prancūzija

Date of authorisation

2017-07-19

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(4)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection in vial	1 ml
Insulinas lispro	100 V

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
68886	83483	1083483	flakonas	10 ml N1		Receptinis	EU/1/17/1203/007	Netiekiama	-	-	No	-	-
68887	83484	1083484	flakonas	10 ml N5		Receptinis	EU/1/17/1203/008	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-07-19	Registruotas